Enovis Corporation

The current price of ENOV is $28.62 — it has increased by 17.20% since the previous close. Data as of Nov 5, 2026.

ENOV is up 29.09% over the past week, up 57.25% over the past month and up 0.70% over the past year. The price is above its 200-day moving average of $23.05.

Analysts' average 12-month price target for ENOV is $37.33, which implies 30.43% upside from the current price. Individual estimates range from $27.00 to $45.00.

Of the 13 analysts covering Enovis Corporation, 2 rate it a strong buy, 10 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Enovis Corporation has a market capitalization of $1.65B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Enovis Corporation posted earnings of $0.88 per share against an estimate of $0.767, beating expectations by 14.73%. Upcoming reports are listed in the earnings calendar.

Enovis Corporation reported revenue of $558.73M in its most recent quarter, which has increased by 1.79% compared with the same quarter a year earlier. Analysts had expected $557.12M.

Enovis Corporation has not paid any dividends over the past year.

Companies most comparable to Enovis Corporation include ITT Inc., IDEX Corporation, Watts Water Technologies, Inc., Donaldson Company, Inc. and The Middleby Corporation.

In the latest trading session ENOV moved between $26.89 and $29.89, a range of 10.50% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Enovis Corporation shows a strong buy rating today and a buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.

Over the past 52 weeks ENOV has traded between $16.70 and $32.41. The current price is 11.69% below its 52-week high.